Taylor C. Harris
CIK 1560168 · Chief Executive Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CUTR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PLEASANTON, CA 94588
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESTA | Director | 1,949 | $62.46 | $121.7K | $0 | 2 | 2026-07-01 |
| PRCT | Director | 137,565 | $19.20 | $2.64M | $250.0K | 7 | 2026-06-10 |
| CUTERA INC (CUTR) Delisted | Chief Executive Officer | 255,744 | $0.10 | $24.8K | $297.3K | 9 | 2025-02-21 |
| MyoKardia, Inc. (MYOK) Delisted | Chief Financial Officer | 8,743 | — | — | -$247.1K | 7 | 2020-04-07 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | SVP & Chief Financial Officer | 0 | — | — | $0 | 3 | 2017-04-28 |
| THOR | VP, Chief Financial Officer | 36,742 | $25.78 | $947.0K | $0 | 16 | 2015-10-08 |
Recent Filings · Page 2 of 5
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-14 | CUTERA INC (CUTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-30 | CUTERA INC (CUTR) Delisted | Buy (P) | +30,000 | $297.3K | EDGAR |
| 2023-08-22 | CUTERA INC (CUTR) Delisted | Grant (A) | +249,336 | $0 | EDGAR |
| 2023-06-16 | PRCT | Grant (A) | +2,711 | $0 | EDGAR |
| 2023-05-23 | CUTERA INC (CUTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | PRCT | Grant (A) | +2,001 | $75.0K | EDGAR |
| 2021-09-21 | PRCT | Mixed | +45,074 | $250.0K | EDGAR |
| 2021-09-16 | PRCT | Grant (A) | — | $0 | EDGAR |
| 2020-11-19 | — | Mixed | −42,559 | $0 | |
| 2020-04-07 | MyoKardia, Inc. (MYOK) Delisted | Mixed | +2,445 | -$61.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.